Published in Magn Reson Med on September 01, 2006
Chemical exchange saturation transfer (CEST): what is in a name and what isn't? Magn Reson Med (2011) 4.08
Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments. Magn Reson Med (2009) 3.57
Chemical exchange saturation transfer contrast agents for magnetic resonance imaging. Annu Rev Biomed Eng (2008) 3.53
Magnetic resonance imaging of glutamate. Nat Med (2012) 3.17
Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging. Magn Reson Med (2008) 2.93
Quantitative description of the asymmetry in magnetization transfer effects around the water resonance in the human brain. Magn Reson Med (2007) 2.76
Simultaneous in vivo positron emission tomography and magnetic resonance imaging. Proc Natl Acad Sci U S A (2008) 2.50
In vivo mapping of brain myo-inositol. Neuroimage (2010) 2.02
In vivo three-dimensional whole-brain pulsed steady-state chemical exchange saturation transfer at 7 T. Magn Reson Med (2011) 1.78
MR imaging of high-grade brain tumors using endogenous protein and peptide-based contrast. Neuroimage (2010) 1.74
Amide proton transfer imaging of 9L gliosarcoma and human glioblastoma xenografts. NMR Biomed (2008) 1.70
CEST: from basic principles to applications, challenges and opportunities. J Magn Reson (2012) 1.59
High-throughput screening of chemical exchange saturation transfer MR contrast agents. Contrast Media Mol Imaging (2010) 1.59
Nuclear Overhauser enhancement (NOE) imaging in the human brain at 7T. Neuroimage (2013) 1.58
Fast 3D chemical exchange saturation transfer (CEST) imaging of the human brain. Magn Reson Med (2010) 1.52
In vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastoma. Proc Natl Acad Sci U S A (2014) 1.44
Saturation power dependence of amide proton transfer image contrasts in human brain tumors and strokes at 3 T. Magn Reson Med (2011) 1.43
Amide proton transfer imaging with improved robustness to magnetic field inhomogeneity and magnetization transfer asymmetry using saturation with frequency alternating RF irradiation. Magn Reson Med (2011) 1.43
Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement. J Magn Reson Imaging (2013) 1.43
Amide proton transfer imaging of the breast at 3 T: establishing reproducibility and possible feasibility assessing chemotherapy response. Magn Reson Med (2012) 1.35
Method for high-resolution imaging of creatine in vivo using chemical exchange saturation transfer. Magn Reson Med (2013) 1.31
Development of chemical exchange saturation transfer at 7 T. Magn Reson Med (2011) 1.26
Simplified and scalable numerical solution for describing multi-pool chemical exchange saturation transfer (CEST) MRI contrast. J Magn Reson (2010) 1.26
Fast multislice pH-weighted chemical exchange saturation transfer (CEST) MRI with Unevenly segmented RF irradiation. Magn Reson Med (2010) 1.18
Optimizing pulsed-chemical exchange saturation transfer imaging sequences. Magn Reson Med (2011) 1.16
Quantitative tissue pH measurement during cerebral ischemia using amine and amide concentration-independent detection (AACID) with MRI. J Cereb Blood Flow Metab (2014) 1.15
On the origins of chemical exchange saturation transfer (CEST) contrast in tumors at 9.4 T. NMR Biomed (2014) 1.14
Detecting activity-evoked pH changes in human brain. Proc Natl Acad Sci U S A (2012) 1.11
Defining an Acidosis-Based Ischemic Penumbra from pH-Weighted MRI. Transl Stroke Res (2011) 1.11
A new method for detecting exchanging amide protons using chemical exchange rotation transfer. Magn Reson Med (2012) 1.09
Chemical Exchange Saturation Transfer (CEST) Imaging: Description of Technique and Potential Clinical Applications. Curr Radiol Rep (2013) 1.08
Quantitative assessment of amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging with extrapolated semi-solid magnetization transfer reference (EMR) signals: Application to a rat glioma model at 4.7 tesla. Magn Reson Med (2015) 1.03
Keyhole chemical exchange saturation transfer. Magn Reson Med (2012) 1.02
Improved measurement of labile proton concentration-weighted chemical exchange rate (k(ws)) with experimental factor-compensated and T(1) -normalized quantitative chemical exchange saturation transfer (CEST) MRI. Contrast Media Mol Imaging (2012) 1.00
Imaging of glutamate neurotransmitter alterations in Alzheimer's disease. NMR Biomed (2012) 1.00
Imaging of glutamate in the spinal cord using GluCEST. Neuroimage (2013) 0.99
Contributors to contrast between glioma and brain tissue in chemical exchange saturation transfer sensitive imaging at 3 Tesla. Neuroimage (2014) 0.98
MICEST: a potential tool for non-invasive detection of molecular changes in Alzheimer's disease. J Neurosci Methods (2012) 0.96
Three-dimensional turbo-spin-echo amide proton transfer MR imaging at 3-Tesla and its application to high-grade human brain tumors. Mol Imaging Biol (2013) 0.95
Imaging amide proton transfer and nuclear overhauser enhancement using chemical exchange rotation transfer (CERT). Magn Reson Med (2013) 0.94
Characterization of lung cancer by amide proton transfer (APT) imaging: an in-vivo study in an orthotopic mouse model. PLoS One (2013) 0.92
Evaluation of the dependence of CEST-EPI measurement on repetition time, RF irradiation duty cycle and imaging flip angle for enhanced pH sensitivity. Phys Med Biol (2013) 0.91
Quantitative chemical exchange saturation transfer (qCEST) MRI--RF spillover effect-corrected omega plot for simultaneous determination of labile proton fraction ratio and exchange rate. Contrast Media Mol Imaging (2014) 0.90
Current and emerging quantitative magnetic resonance imaging methods for assessing and predicting the response of breast cancer to neoadjuvant therapy. Breast Cancer (Dove Med Press) (2012) 0.87
A combined analytical solution for chemical exchange saturation transfer and semi-solid magnetization transfer. NMR Biomed (2014) 0.87
Application of chemical exchange saturation transfer (CEST) MRI for endogenous contrast at 7 Tesla. J Neuroimaging (2013) 0.86
Alternate ascending/descending directional navigation approach for imaging magnetization transfer asymmetry. Magn Reson Med (2010) 0.86
UCEPR: Ultrafast localized CEST-spectroscopy with PRESS in phantoms and in vivo. Magn Reson Med (2015) 0.85
Imaging of endogenous exchangeable proton signals in the human brain using frequency labeled exchange transfer imaging. Magn Reson Med (2013) 0.84
Noninvasive imaging of infection after treatment with tumor-homing bacteria using Chemical Exchange Saturation Transfer (CEST) MRI. Magn Reson Med (2013) 0.84
Quantitative assessment of the effects of water proton concentration and water T1 changes on amide proton transfer (APT) and nuclear overhauser enhancement (NOE) MRI: The origin of the APT imaging signal in brain tumor. Magn Reson Med (2016) 0.83
Emerging Techniques in Brain Tumor Imaging: What Radiologists Need to Know. Korean J Radiol (2016) 0.83
A new NOE-mediated MT signal at around -1.6ppm for detecting ischemic stroke in rat brain. Magn Reson Imaging (2016) 0.83
pCEST: Positive contrast using Chemical Exchange Saturation Transfer. J Magn Reson (2011) 0.83
Amide proton transfer-weighted imaging of the head and neck at 3 T: a feasibility study on healthy human subjects and patients with head and neck cancer. NMR Biomed (2014) 0.83
Amide proton transfer imaging of the human brain. Methods Mol Biol (2011) 0.83
A review of optimization and quantification techniques for chemical exchange saturation transfer MRI toward sensitive in vivo imaging. Contrast Media Mol Imaging (2015) 0.81
Imaging of amide proton transfer and nuclear Overhauser enhancement in ischemic stroke with corrections for competing effects. NMR Biomed (2014) 0.81
MR imaging of a novel NOE-mediated magnetization transfer with water in rat brain at 9.4 T. Magn Reson Med (2016) 0.81
Imaging the accumulation and suppression of tau pathology using multiparametric MRI. Neurobiol Aging (2015) 0.80
Multiparametric MRI reveals dynamic changes in molecular signatures of injured spinal cord in monkeys. Magn Reson Med (2014) 0.80
Molecular magnetic resonance imaging in cancer. J Transl Med (2015) 0.79
R1 correction in amide proton transfer imaging: indication of the influence of transcytolemmal water exchange on CEST measurements. NMR Biomed (2015) 0.79
Accuracy and uncertainty of asymmetric magnetization transfer ratio quantification for amide proton transfer (APT) imaging at 3T: a Monte Carlo study. Conf Proc IEEE Eng Med Biol Soc (2013) 0.78
Chemical exchange saturation transfer (CEST) MR technique for in-vivo liver imaging at 3.0 tesla. Eur Radiol (2015) 0.78
The Deakin/Graeff hypothesis: focus on serotonergic inhibition of panic. Neurosci Biobehav Rev (2014) 0.78
Optimization of 7-T chemical exchange saturation transfer parameters for validation of glycosaminoglycan and amide proton transfer of fibroglandular breast tissue. Radiology (2014) 0.77
Mapping murine diabetic kidney disease using chemical exchange saturation transfer MRI. Magn Reson Med (2015) 0.77
Quantitative chemical exchange saturation transfer (CEST) MRI of glioma using Image Downsampling Expedited Adaptive Least-squares (IDEAL) fitting. Sci Rep (2017) 0.76
Characterizing amide proton transfer imaging in haemorrhage brain lesions using 3T MRI. Eur Radiol (2016) 0.76
Added value of amide proton transfer imaging to conventional and perfusion MR imaging for evaluating the treatment response of newly diagnosed glioblastoma. Eur Radiol (2016) 0.76
Novel gradient echo sequence‑based amide proton transfer magnetic resonance imaging in hyperacute cerebral infarction. Mol Med Rep (2015) 0.75
Nuclear Overhauser Enhancement imaging of glioblastoma at 7 Tesla: region specific correlation with apparent diffusion coefficient and histology. PLoS One (2015) 0.75
MR Imaging Biomarkers in Oncology Clinical Trials. Magn Reson Imaging Clin N Am (2016) 0.75
Insight into the quantitative metrics of chemical exchange saturation transfer (CEST) imaging. Magn Reson Med (2016) 0.75
Assessment of Glioma Response to Radiotherapy Using Multiple MRI Biomarkers with Manual and Semiautomated Segmentation Algorithms. J Neuroimaging (2016) 0.75
A Potential Magnetic Resonance Imaging Technique Based on Chemical Exchange Saturation Transfer for In Vivo γ-Aminobutyric Acid Imaging. PLoS One (2016) 0.75
Molecular Imaging Using Endogenous Cellular Proteins. Bo Pu Xue Za Zhi (2013) 0.75
Investigating hydroxyl chemical exchange using a variable saturation power chemical exchange saturation transfer (vCEST) method at 3 T. Magn Reson Med (2015) 0.75
A patient-specific therapeutic approach for tumour cell population extinction and drug toxicity reduction using control systems-based dose-profile design. Theor Biol Med Model (2013) 0.75
Amide proton transfer imaging for differentiation of benign and atypical meningiomas. Eur Radiol (2017) 0.75
Fiber tract-based atlas of human white matter anatomy. Radiology (2003) 10.18
Fiber tracking: principles and strategies - a technical review. NMR Biomed (2002) 8.52
DtiStudio: resource program for diffusion tensor computation and fiber bundle tracking. Comput Methods Programs Biomed (2006) 7.65
Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med (2003) 6.57
Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. Neuroimage (2007) 5.23
Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan: Response. Radiology (2017) 4.99
Amide proton transfer (APT) contrast for imaging of brain tumors. Magn Reson Med (2003) 4.57
Determining the longitudinal relaxation time (T1) of blood at 3.0 Tesla. Magn Reson Med (2004) 4.25
Artificial reporter gene providing MRI contrast based on proton exchange. Nat Biotechnol (2007) 3.87
Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participants. Neuroimage (2009) 3.74
Imaging cortical association tracts in the human brain using diffusion-tensor-based axonal tracking. Magn Reson Med (2002) 3.67
Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med (2010) 3.62
Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments. Magn Reson Med (2009) 3.57
Multi-parametric neuroimaging reproducibility: a 3-T resource study. Neuroimage (2010) 3.32
Pediatric diffusion tensor imaging: normal database and observation of the white matter maturation in early childhood. Neuroimage (2005) 3.11
In vivo imaging of glucose uptake and metabolism in tumors. Nat Med (2013) 3.01
Performance evaluation of the GE healthcare eXplore VISTA dual-ring small-animal PET scanner. J Nucl Med (2006) 2.98
Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging. Magn Reson Med (2008) 2.93
Autoimmune hypophysitis. Endocr Rev (2005) 2.86
Human brain white matter atlas: identification and assignment of common anatomical structures in superficial white matter. Neuroimage (2008) 2.86
Detection of the ischemic penumbra using pH-weighted MRI. J Cereb Blood Flow Metab (2006) 2.77
Quantitative description of the asymmetry in magnetization transfer effects around the water resonance in the human brain. Magn Reson Med (2007) 2.76
Spatial normalization of diffusion tensor fields. Magn Reson Med (2003) 2.70
Functional magnetic resonance imaging based on changes in vascular space occupancy. Magn Reson Med (2003) 2.68
[18F]fluorodeoxyglucose positron emission tomography correlates with Akt pathway activity but is not predictive of clinical outcome during mTOR inhibitor therapy. J Clin Oncol (2009) 2.67
Coordination of voluntary and stimulus-driven attentional control in human cortex. Psychol Sci (2005) 2.57
White and gray matter development in human fetal, newborn and pediatric brains. Neuroimage (2006) 2.55
New "multicolor" polypeptide diamagnetic chemical exchange saturation transfer (DIACEST) contrast agents for MRI. Magn Reson Med (2008) 2.48
Effects of signal-to-noise ratio on the accuracy and reproducibility of diffusion tensor imaging-derived fractional anisotropy, mean diffusivity, and principal eigenvector measurements at 1.5 T. J Magn Reson Imaging (2007) 2.44
Multi-contrast human neonatal brain atlas: application to normal neonate development analysis. Neuroimage (2011) 2.41
Model-free arterial spin labeling quantification approach for perfusion MRI. Magn Reson Med (2006) 2.40
Analysis of noise effects on DTI-based tractography using the brute-force and multi-ROI approach. Magn Reson Med (2004) 2.35
Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. Biochem Biophys Res Commun (2004) 2.29
Oxygenation and hematocrit dependence of transverse relaxation rates of blood at 3T. Magn Reson Med (2007) 2.22
Atlas-guided tract reconstruction for automated and comprehensive examination of the white matter anatomy. Neuroimage (2010) 2.21
Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. J Am Coll Cardiol (2009) 2.20
Noninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment. Antimicrob Agents Chemother (2009) 2.18
Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke (2008) 2.18
Control of object-based attention in human cortex. Cereb Cortex (2004) 2.16
Mechanism of magnetization transfer during on-resonance water saturation. A new approach to detect mobile proteins, peptides, and lipids. Magn Reson Med (2003) 2.14
DTI tractography based parcellation of white matter: application to the mid-sagittal morphology of corpus callosum. Neuroimage (2005) 2.13
Optimization of the irradiation power in chemical exchange dependent saturation transfer experiments. J Magn Reson (2005) 2.11
Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer. Clin Cancer Res (2005) 2.10
Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA). J Med Chem (2008) 2.03
Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer. Cancer Res (2009) 2.03
Multi-contrast large deformation diffeomorphic metric mapping for diffusion tensor imaging. Neuroimage (2009) 2.01
Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer. J Nucl Med (2012) 2.00
N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer. Clin Cancer Res (2008) 2.00
Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions. J Infect Dis (2011) 1.96
Routine clinical brain MRI sequences for use at 3.0 Tesla. J Magn Reson Imaging (2005) 1.94
Theoretical and experimental investigation of the VASO contrast mechanism. Magn Reson Med (2006) 1.94
The QUASAR reproducibility study, Part II: Results from a multi-center Arterial Spin Labeling test-retest study. Neuroimage (2009) 1.92
Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer. Mol Imaging Biol (2015) 1.90
NAAG peptidase inhibitors and their potential for diagnosis and therapy. Nat Rev Drug Discov (2005) 1.89
Atlas-based analysis of neurodevelopment from infancy to adulthood using diffusion tensor imaging and applications for automated abnormality detection. Neuroimage (2010) 1.89
A framework for callosal fiber distribution analysis. Neuroimage (2002) 1.87
Natural D-glucose as a biodegradable MRI contrast agent for detecting cancer. Magn Reson Med (2012) 1.84
Simplified quantitative description of amide proton transfer (APT) imaging during acute ischemia. Magn Reson Med (2007) 1.83
Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expression. Nat Med (2010) 1.81
Three-dimensional anatomical characterization of the developing mouse brain by diffusion tensor microimaging. Neuroimage (2003) 1.80
Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer. J Med Chem (2008) 1.79
In vivo three-dimensional whole-brain pulsed steady-state chemical exchange saturation transfer at 7 T. Magn Reson Med (2011) 1.78
Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging. Radiology (2003) 1.77
MR imaging of high-grade brain tumors using endogenous protein and peptide-based contrast. Neuroimage (2010) 1.74
Amide proton transfer MR imaging of prostate cancer: a preliminary study. J Magn Reson Imaging (2011) 1.73
Sustained poststimulus elevation in cerebral oxygen utilization after vascular recovery. J Cereb Blood Flow Metab (2004) 1.72
Cerebral artery dilatation maintains cerebral oxygenation at extreme altitude and in acute hypoxia--an ultrasound and MRI study. J Cereb Blood Flow Metab (2011) 1.71
Developing MR reporter genes: promises and pitfalls. NMR Biomed (2007) 1.70
Amide proton transfer imaging of 9L gliosarcoma and human glioblastoma xenografts. NMR Biomed (2008) 1.70
2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer. Clin Cancer Res (2011) 1.69
Sensitive CEST agents based on nucleic acid imino proton exchange: detection of poly(rU) and of a dendrimer-poly(rU) model for nucleic acid delivery and pharmacology. Magn Reson Med (2003) 1.68
Suppression of human glioma xenografts with second-generation IL13R-specific chimeric antigen receptor-modified T cells. Clin Cancer Res (2012) 1.67
Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil. Proc Natl Acad Sci U S A (2005) 1.65
Multiparametric magnetic resonance imaging analysis of the corticospinal tract in multiple sclerosis. Neuroimage (2007) 1.62
High-throughput screening of chemical exchange saturation transfer MR contrast agents. Contrast Media Mol Imaging (2010) 1.59
Nuclear Overhauser enhancement (NOE) imaging in the human brain at 7T. Neuroimage (2013) 1.58
Experimental measurement of extravascular parenchymal BOLD effects and tissue oxygen extraction fractions using multi-echo VASO fMRI at 1.5 and 3.0 T. Magn Reson Med (2005) 1.56
In vivo differentiation of N-acetyl aspartyl glutamate from N-acetyl aspartate at 3 Tesla. Magn Reson Med (2007) 1.55
MRI-detectable pH nanosensors incorporated into hydrogels for in vivo sensing of transplanted-cell viability. Nat Mater (2013) 1.53
Superhigh-throughput needleless electrospinning using a rotary cone as spinneret. Small (2010) 1.52
Fast 3D chemical exchange saturation transfer (CEST) imaging of the human brain. Magn Reson Med (2010) 1.52
On the relationship between seed-based and ICA-based measures of functional connectivity. Magn Reson Med (2011) 1.51
68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer. J Med Chem (2010) 1.51
Correction of B0 susceptibility induced distortion in diffusion-weighted images using large-deformation diffeomorphic metric mapping. Magn Reson Imaging (2008) 1.48
Brain white matter anatomy of tumor patients evaluated with diffusion tensor imaging. Ann Neurol (2002) 1.46
MR tracking of transplanted cells with "positive contrast" using manganese oxide nanoparticles. Magn Reson Med (2008) 1.46